Gastroenterology and Liver

Gut Microbiome & Therapeutics

The gut microbiome plays a pivotal role in gastrointestinal and liver health, influencing immunity, metabolism, and disease pathogenesis. This session explores the latest research on microbiota composition, function, and interactions with the host in conditions such as IBD, NAFLD, obesity, and gastrointestinal cancers. Participants will gain insights into the therapeutic potential of microbiome modulation through probiotics, prebiotics, fecal microbiota transplantation, and diet-based interventions. Studies examining microbiome-based biomarkers for diagnosis, prognosis, and treatment response will also be presented, fostering innovation and translational research.

In addition, this track emphasizes personalized approaches to microbiome therapy, integrating genomic, metabolomic, and immunological profiling to optimize patient outcomes. Clinical trials, animal models, and case studies will highlight emerging strategies to harness the gut microbiome for disease prevention and treatment. Discussions will also include safety, regulatory considerations, and ethical implications of microbiome-based interventions. Attendees will leave the session equipped with cutting-edge knowledge, practical applications, and research opportunities in this rapidly evolving field, making it highly relevant for both clinicians and researchers.